"We have the evidence now to show that it does work," said Michael Traeger, a research fellow at Boston's Harvard Pilgrim Health Care Institute, referencing the significant reduction in sexually transmitted infections observed among doxyPEP users in northern California. Notably, his co-authored study showed a remarkable 79% reduction in chlamydia, an 80% drop in syphilis, and a 12% decrease in gonorrhea following the introduction of doxyPEP, demonstrating its effectiveness in combating these public health threats.
"The studies provide 'welcome evidence' for the effectiveness of doxyPEP in preventing syphilis and chlamydia among an early-adopter group of men and transgender women," wrote Jeanne Marrazzo and Jodie Dionne in their editorial. They highlighted the potential for doxyPEP to address pressing public health issues and suggested that these findings could guide further research aimed at reinforcing and expanding preventive measures against sexually transmitted infections.
#public-health #sexually-transmitted-infections #doxypep #antibiotic-resistance #syphilis-and-chlamydia-reduction
Collection
[
|
...
]